NEXENTIS TECHNOLOGIES INC. Stock Issued During Period, Value, Conversion of Convertible Securities
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- NEXENTIS TECHNOLOGIES INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2023-09-30 was $1.66M.
- NEXENTIS TECHNOLOGIES INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2023-06-30 was $826.71K.
- NEXENTIS TECHNOLOGIES INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2021-06-30 was $648.41K, a 10.66% increase year-over-year.
- NEXENTIS TECHNOLOGIES INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2020-12-31 was -$34.70K.
- NEXENTIS TECHNOLOGIES INC. stock issued during period, value, conversion of convertible securities for fiscal 2023 was $827.00K.
- NEXENTIS TECHNOLOGIES INC. stock issued during period, value, conversion of convertible securities for fiscal 2021 was $648.41K, a 10.66% increase from fiscal 2020.
- NEXENTIS TECHNOLOGIES INC. stock issued during period, value, conversion of convertible securities for fiscal 2020 was $585.93K.
| Period end | Stock Issued During Period, Value, Conversion of Convertible Securities 3 month | Stock Issued During Period, Value, Conversion of Convertible Securities 12 month |
|---|---|---|
| 2023-12-31 | $827.00K 10-K · filed 2025-03-31 | |
| 2023-09-30 | $1.66M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $826.71K 10-Q · filed 2023-11-14 | |
| 2021-12-31 | $648.41K 10-K · filed 2023-03-27 | |
| 2021-06-30 | $648.41K 10-Q · filed 2022-11-14 | |
| 2020-12-31 | -$34.70K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $585.93K 10-K · filed 2022-03-31 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | |
| 2020-06-30 | $585.93K 10-Q · filed 2021-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |